首页> 外文期刊>Analytical Chemistry >Analysis of Large Peptides by MALDI Using a Linear Quadrupole Ion Trap with Mass Range Extension
【24h】

Analysis of Large Peptides by MALDI Using a Linear Quadrupole Ion Trap with Mass Range Extension

机译:使用线性四极杆离子阱并进行质量范围扩展的MALDI分析大肽

获取原文
获取原文并翻译 | 示例
       

摘要

Analysis of large peptides can be used to discover or tonmonitor biomarkers for various diseases. For example, thenlevels of such peptides can determine the effectiveness ofnan experimental drug or the progress of a disease. Manynmass spectrometric methods for monitoring these peptidesnuse MALDI-ToF instruments because of their high molecularnweights, although such instruments typically lack MSMS or MSn capabilities. Here, them/z range of a MALDILITninstrument was extended tom/z 5500 for the MS ornMSn analysis of large peptides. Instrument performancenwas examined using amyloid u0001 1-40 and 1-42 (avg.nMW 4330.8 and 4515.0, respectively), large peptidesnthat comprise the bulk of neuritic plaques and arenpotential biomarkers for Alzheimer’s Disease. The amyloidnu0001 1-40 was detected in the full-scan mass spectrumnwith sufficient resolution to distinguish and match thenexpected isotopic pattern. The MS/MS product ionnspectra of both peptides matched the expected fragmentationnpatterns; up to MS4 experiments were performednto verify the identity of the peptides. These experimentsnclearly demonstrate the advantages of this approach,nincluding MSn experiments for structural elucidation andnsimplified spectra due to singly charged parent ions, fornlarge peptides.
机译:大肽的分析可用于发现或监测各种疾病的生物标记。例如,这样的肽的水平可以决定实验药物的有效性或疾病的进展。 MALDI-ToF仪器因分子量高而用于监测这些肽的许多质谱法,尽管此类仪器通常缺乏MS / nMS或MSn功能。在这里,MALDILITn仪器的它们/ z范围扩大到了m / z 5500,以用于大肽段的MS ornMSn分析。使用淀粉样蛋白u0001 1-40和1-42(分别平均nMW 4330.8和4515.0),包含大部分神经炎斑块和阿尔茨海默氏病等生物标记物的大肽对仪器性能进行了检查。在全扫描质谱中检测到淀粉样蛋白00010001,具有足够的分辨率以区分和匹配然后预期的同位素模式。两种肽的MS / MS产物离子谱均符合预期的断裂模式。最多进行MS4实验,以验证肽的身份。这些实验清楚地证明了这种方法的优势,其中包括由于单电荷母体离子,大型肽而进行的结构解析和简化光谱的MSn实验。

著录项

  • 来源
    《Analytical Chemistry》 |2010年第3期|p.930-934|共5页
  • 作者单位

    Department of Chemistry, University of Florida, Gainesville, Florida 32611, Department of Medicine, University ofFlorida, Gainesville, Florida 32610, and Research and Development, Pharmaceutical Candidate Optimization,Discovery Analytical Sciences, Bristol-Myers Squibb Company, Wallingford, Connecticut 06492;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 13:36:36

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号